Frequent expression of MAGE1 tumor antigens in bronchial epithelium of smokers without lung cancer

Bhutani,Manisha; Kumar Pathak,Ashutosh; Tang,Hongli; Fan,You  H.; Liu,Diane  D.; Lee,J.   Jack; Kurie,Jonathan; Morice,Rodolfo C.; Hong,Waun   Ki; Mao,Li

doi:10.3892/etm.2010.176

Frequent expression of MAGE1 tumor antigens in bronchial epithelium of smokers without lung cancer

Authors:
- Manisha Bhutani
- Ashutosh Kumar Pathak
- Hongli Tang
- You H. Fan
- Diane D. Liu
- J. Jack Lee
- Jonathan Kurie
- Rodolfo C. Morice
- Waun Ki Hong
- Li Mao
View Affiliations

Affiliations: Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA, Department of Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA, Department of Pulmonary Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA, Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, MD 21201, USA
Published online on: December 2, 2010 https://doi.org/10.3892/etm.2010.176
Pages: 137-142

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Melanoma antigens (MAGE) are frequently expressed in lung cancer and are promising targets of anti-cancer immunotherapy. Our preliminary data suggested that MAGE may be expressed during early lung carcinogenesis, raising the possibility of targeting MAGE as a lung cancer prevention strategy. The purpose of this study was to investigate MAGE activation patterns in the airways of chronic smokers without lung cancer. MAGE-A1, -A3 and -B2 gene expression was determined in bronchial brush cells from chronic former smokers without lung cancer by reverse transcription-PCR (RT-PCR). The results were correlated with clinical parameters. The 123 subjects had a median age of 57 years, a median of 40 pack-years smoking history, and had quit smoking for at least one year prior to enrollment. Among the subjects, 31 (25%), 38 (31%), and 46 (37%) had detectable MAGE-A1, -A3 and -B2 expression, respectively, in their bronchial brush samples. Expression of MAGE-A1 and -B2 positively correlated with pack-years smoking history (P=0.03 and 0.03, respectively). The frequency of expression did not decrease despite a prolonged smoking cessation period. In conclusion, MAGE-A1, -A3 and -B2 genes are frequently expressed in the bronchial epithelial cells of chronic smokers without lung cancer, suggesting that chronic exposure to cigarette smoke activates these genes even before the malignant transformation of bronchial cells in susceptible individuals. Once activated, the expression persists despite long-term smoking cessation. These data support the targeting of MAGE as a novel lung cancer prevention strategy.

View Figures

View References

1.	Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E and Schuler G: Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med. 190:1669–1678. 1999. View Article : Google Scholar
2.	Godelaine D, Carrasco J, Lucas S, Karanikas V, Schuler-Thurner B, Coulie PG, Schuler G, Boon T and Van Pel A: Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide. J Immunol. 171:4893–4897. 2003. View Article : Google Scholar : PubMed/NCBI
3.	Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB and Lyerly HK: A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 3:92005. View Article : Google Scholar : PubMed/NCBI
4.	Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61:5544–5551. 2001.PubMed/NCBI
5.	Barker PA and Salehi A: The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res. 67:705–712. 2002. View Article : Google Scholar : PubMed/NCBI
6.	Osterlund C, Tohonen V, Forslund KO and Nordqvist K: Mage-b4, a novel melanoma antigen (MAGE) gene specifically expressed during germ cell differentiation. Cancer Res. 60:1054–1061. 2004.PubMed/NCBI
7.	Sakata M: Expression of MAGE gene family in lung cancers. Kurume Med J. 43:55–61. 1996. View Article : Google Scholar : PubMed/NCBI
8.	Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK and Mao L: Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res. 61:7959–7963. 2001.PubMed/NCBI
9.	Atanackovic D, Altorki NK, Stockert E, Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA, Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G, Old LJ and Gnjatic S: Vaccine-induced CD4⁺ T cell responses to MAGE-3 protein in lung cancer patients. J Immunol. 172:3289–3296. 2004.PubMed/NCBI
10.	Fischer C, Gudat F, Stulz P, Noppen C, Schaefer C, Zajac P, Trutmann M, Kocher T, Zuber M, Harder F, Heberer M and Spagnoli GC: High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int J Cancer. 71:1119–1121. 1997. View Article : Google Scholar : PubMed/NCBI
11.	Sienel W, Varwerk C, Linder A, Kaiser D, Teschne M, Delire M, Stamatis G and Passlick B: Melanoma associated antigen (MAGE)-A3 expression in stages I and II non-small cell lung cancer: results of a multi-center study. Eur J Cardiothorac Surg. 25:131–134. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA and Franklin WA: Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 62:3971–3979. 2002.PubMed/NCBI
13.	Tajima K, Obata Y, Tamaki H, Yoshida M, Chen YT, Scanlan MJ, Old LJ, Kuwano H, Takahashi T, Takahashi T and Mitsudomi T: Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer. 42:23–33. 2003. View Article : Google Scholar : PubMed/NCBI
14.	De Plaen E, Arden K, Traversari C, et al: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics. 40:360–369. 1994.PubMed/NCBI
15.	Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP and Boon T: Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics. 46:397–408. 1997. View Article : Google Scholar : PubMed/NCBI
16.	Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C and Boon T: Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res. 58:743–752. 1998.PubMed/NCBI
17.	Gillespie AM and Coleman RE: The potential of melanoma antigen expression in cancer therapy. Cancer Treat Rev. 25:219–227. 1999. View Article : Google Scholar : PubMed/NCBI
18.	Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S and Boon T: A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med. 182:689–698. 1995.
19.	Van Baren N, Brasseur F, Godelaine D, Hames G, Ferrant A, Lehmann F, Andre M, Ravoet C, Doyen C, Spagnoli GC, Bakkus M, Thielemans K and Boon T: Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood. 94:1156–1164. 1999.PubMed/NCBI
20.	Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen YT, Spagnoli GC and Old LJ: Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer. 85:460–465. 2000. View Article : Google Scholar : PubMed/NCBI
21.	Peikert T, Specks U, Farver C, Erzurum SC and Comhair SA: Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res. 66:4693–4700. 2006. View Article : Google Scholar : PubMed/NCBI
22.	Laduron S, Deplus R, Zhou S, Kholmanskikh O, Godelaine D, De Smet C, Hayward SD, Fuks F, Boon T and De Plaen E: MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res. 32:4340–4350. 2004. View Article : Google Scholar : PubMed/NCBI
23.	Morishima N, Nakanishi K, Takenouchi H, Shibata T and Yasuhiko Y: An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem. 277:34287–34294. 2002. View Article : Google Scholar : PubMed/NCBI
24.	De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F and Boon T: The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA. 93:7149–7153. 1996.PubMed/NCBI
25.	Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H and Jaenisch R: Induction of tumors in mice by genomic hypomethylation. Science. 300:489–492. 2003. View Article : Google Scholar : PubMed/NCBI
26.	Eden A, Gaudet F, Waghmare A and Jaenisch R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 300:4552003. View Article : Google Scholar : PubMed/NCBI
27.	Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang J, Marinelli B, Pesatori AC, Bertazzi PA and Yang AS: Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67:876–880. 2007. View Article : Google Scholar : PubMed/NCBI
28.	Wang L, Wang J, Sun S, Rodriguez M, Yue P, Jang SJ and Mao L: A novel DNMT3B subfamily, ΔDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. Int J Oncol. 29:201–207. 2006.
29.	Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A and Sowers LC: Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32:4100–4108. 2004. View Article : Google Scholar : PubMed/NCBI
30.	Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN and Hong WK: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 89:857–862. 1997. View Article : Google Scholar : PubMed/NCBI
31.	Wistuba II, Mao L and Gazdar AF: Smoking molecular damage in bronchial epithelium. Oncogene. 21:7298–7306. 2002. View Article : Google Scholar : PubMed/NCBI
32.	Peto R, Darby S, Deo H, Silcocks P, Whitley E and Doll R: Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 321:323–329. 2000. View Article : Google Scholar : PubMed/NCBI